# Joachim R. Kalden

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/joachim-r-kalden/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,519 |
| Field | T-cell and B-cell Immunology |
| h-index | 49 |
| i10-index | 88 |
| Last Known Institution | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| OpenAlex ID | https://openalex.org/A5105366464 |
| Works | 124 |

## Researcher papers

- [Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis](https://scholariq.org/papers/infliximab-and-methotrexate-in-the-treatment-of-rheumatoid-arthritis/)
- [Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial](https://scholariq.org/papers/infliximab-chimeric-anti-tumour-necrosis-factor-monoclonal-antibody-versus/)
- [The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis](https://scholariq.org/papers/the-proteasome-inhibitor-bortezomib-depletes-plasma-cells-and-protects-mice-with/)

## Researcher topics

- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Phagocytosis and Immune Regulation](https://scholariq.org/topics/phagocytosis-and-immune-regulation/)

## Researcher university

- [Friedrich-Alexander-Universität Erlangen-Nürnberg](https://scholariq.org/institutions/friedrich-alexander-universitat-erlangen-nurnberg/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
